| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5644637 | Annales de Dermatologie et de Vénéréologie | 2017 | 5 Pages |
Abstract
Anti-MDA5 dermatomyositis must be considered systematically in all cases of pulmonary involvement associated with cutaneous signs of dermatomyositis, in which no muscular involvement is generally seen. This condition accounts for up to 7% of DM and carries a severe prognosis due to pulmonary involvement.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
B. Garcia, F. Dabouz, L. Pascal, M. Gillard, P. Modiano,